Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia
2024 · Journal of Cancer Research and Clinical Oncology · 8 citations
https://doi.org/10.1007/s00432-024-05861-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
157
Citations
7
h-index
5
i10-index
Guangyang Weng is an academic researcher from Shenzhen Second People's Hospital. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Histone Deacetylase Inhibitors Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 7, co-authored 31 publications.
ORCID: 0000-0002-7923-8972https://doi.org/10.1007/s00432-024-05861-9
https://doi.org/10.1002/cam4.6885
Click to start Chat